Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients
Clinical trial NCT05503030 · TERMINATED
Trial details
- NCT number
- NCT05503030
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-21
- Primary completion
- 2026-05-13
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.